Progress in Clinical Use of CC Chemokine Receptor 4 Antibody for Regulatory T Cell Suppression
Target antigens Antibody medicines Tumor types Mechanisms of tumor killing Hematopoietic cell differentiation antigens CD20 Rituximab Non-Hodgkin’s lymphoma ADCC Tositumomab Non-Hodgkin’s lymphoma 131I Ibritumomab 90Y CD22 Inotuzumab Non-Hodgkin’s lymphoma Ozogamicin…